2-Bromo-4-isopropylphenylboronic acid, 97%, 100mg

2-(5-Chloro-2-fluorophenyl)-N-(pyridin-4-yl)pteridin-4-amine, 98%, 1g

Ethyl 2,3-difluoro-4-methoxybenzoate, 98%, 1g

(3aR,6aS)-rel-Hexahydro-1H-furo[3,4-c]pyrrole, 95.0%, 1g

N-benzyl-1-methyl-1H-pyrazol-3-amine, 95%, 100mg

Methyl 3-morpholinecarboxylate hydrochloride, 95.0%, 5g

4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine, 95%, 250mg

5-Amino-3-phenyl-1,2,4-thiadiazole, 98.0%, 1g

Ethyl 5-bromo-4-methylthiazole-2-carboxylate, 95%, 5g

Triethylsulfonium-bis-(trifluoromethyl-, sulfonyl)-imide min. 99%, 25 g, glass packaging

2,4-Dibromobenzoic acid, 98.0%, 10g

2-Azabicyclo[2.2.2]octan-3-one, 95.0%, 250mg

Ethyl 3-amino-4-chloro-2-nitrobenzoate, 97%, 250mg